You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
年內最高漲幅超過300%,華爾街稱估值已反應預期
uSMART盈立智投 08-06 22:24

儘管週四公佈的2021年第二季度財報好於預期,但Moderna(MRNA.US)股價仍然持續走低。Oppenheimer和Piper Sandler分析師均下調該股評級,理由是該股的估值已充分反應預期。

Oppenheimer的分析師Hartaj Singh和Justin Kim指出,Moderna今年以來的漲幅最高超過300%,表現遠遠好於納斯達克生物技術指數。

“Moderna當前估值和超千億美元的市值已經充分反映了未來鉅額經常性收入和研發管線進展。”Singh和Kim表示,並將該股的評級從“增持”下調至“持有”。

華爾街分析師們普遍預計,該公司新冠疫苗業務最早將在2023年面臨財務壓力。他們還認爲,該公司的非新冠疫苗研發管道仍需2-3年才能實現商業化。

與此同時,Piper Sandler同樣將Moderna的評級從“增持”下調至“中性”,指出該股目前的估值似乎充分反應了新冠疫苗銷售額的增長預期,但該行給出的目標價仍然維持在445美元。

另外,巴克萊表示重申Moderna“增持”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account